ReviewCureus2025
Determinants of Poor Glycemic Control Among Type 2 Diabetes Patients: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sociodemographic predictors of glycaemic control among adults with type 2 diabetes mellitus in a Nigerian population: implications for public health and service delivery.BMC public health · 2026Article
- Article
- Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus.Molecules (Basel, Switzerland) · 2025Review
- Efficacy and Safety of Once-Weekly IcoSema in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis.AACE endocrinology and diabetesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poor glycemic control remains a pervasive challenge in type 2 diabetes mellitus (T2DM) management, contributing to elevated risks of complications and healthcare burdens globally. This systematic review aimed to synthesize evidence on the determinants of poor glycemic control (hemoglobin A1C (HbA1c) >7%) among adults with T2DM. We followed PRISMA guidelines to search for relevant studies across five different databases, where we found 239 studies. First, the studies were screened for duplicates and then assessed for eligibility by screening through titles, abstracts, and ultimately full text. Upon carefully assessing for eligibility using inclusion and exclusion criteria, only 12 studies were found relevant and were included in this systematic review. The review found that most studies had a moderate risk of bias based on the Newcastle-Ottawa Scale, with only three rated as low risk. Key factors linked to poor glycemic control included low socioeconomic status, medication non-adherence, longer diabetes duration, obesity, insulin-based regimens, and limited access to healthcare. Insulin use, in particular, was paradoxically associated with worse control due to its complexity and adherence challenges, especially in low-resource settings. Regional differences highlighted unique barriers like cultural practices in Ethiopia and gaps in diabetes education in Eritrea. These findings reflect the complex and context-specific nature of glycemic control, especially in low- and middle-income countries. The review calls for simplified treatments, affordable medications, and better management of comorbidities, while encouraging future research using longitudinal and mixed-methods approaches to guide more effective, patient-centered interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.